Straits Times Index
3,292.69 +10.64 (+0.32%) Nikkei
38,274.05 -131.61 (-0.34%) Hang Seng
17,763.03 +16.12 (+0.09%) FTSE 100
8,172.86 +28.73 (+0.35%) Bitcoin USD
56,973.02 -5,369.66 (-8.61%) CMC Crypto 200
1,217.25 -121.82 (-9.09%)
Phibro Animal Health Corporation (PAHC)
After hours:
- Zacks
Phibro (PAHC) Moves 31.8% Higher: Will This Strength Last?
Phibro (PAHC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
- Reuters
Zoetis to sell medicated feed additive portfolio to Phibro in $350 mln deal
Top animal health company Zoetis Inc will sell its medicated feed additive portfolio and certain other assets to animal nutrition company Phibro Animal Health in a $350 million deal, the two companies said on Sunday. The agreement would also involve some of Zoetis' water soluble products and six manufacturing sites across the U.S., Italy and China, the firms said in a statement. More than 300 Zoetis employees across manufacturing, distribution and commercial activities would transition to Phibro Animal Health, they said.
- Business Wire
Zoetis to Sell Medicated Feed Additive Portfolio to Phibro Animal Health
PARSIPPANY, N.J. & TEANECK, N.J., April 28, 2024--Zoetis Inc. (NYSE:ZTS) and Phibro Animal Health Corporation (Nasdaq: PAHC) today announced that they have entered into a definitive agreement where Phibro Animal Health will acquire Zoetis’ medicated feed additive (MFA) product portfolio, certain water soluble products and related assets for $350 million, subject to customary closing adjustments. This transaction is expected to be complete in the second half of calendar year 2024.
